Clinical Trial

The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
As a hypothesis and shown in many meta-analyses and randomized controlled studies, minimally invasive surgery causes less surgical trauma and therefore less proinflammatory response and immunosuppression develop, and postoperative recovery is faster. Although various prognostic studies on the relationship between gastrointestinal cancer types and SII (systemic inflammatory index) and the use of minimally invasive surgery have been published, the high level of this response and the type of surgery in the treatment of colorectal cancer have not yet been shown to have a direct effect on SII.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT06540027
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Conditions Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Cancer, Rectal Cancer Stage, Immune System Disorder
Enrollment 80 participants
Start Date 2024-06-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-15